Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Adrienne Nedved"'
Autor:
Charlotte B. Wagner, Ken Boucher, Adrienne Nedved, Ivana N. Micallef, Sanjal Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A. Brem, Daniel A. Ermann, Lindsey A. Fitzgerald, Boyu Hu, Deborah M. Stephens, Harsh Shah
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Sixteen cycles of Brentuximab vedotin (BV) after autologous stem cell transplant (ASCT) in high-risk relapsed/refractory classical Hodgkin lymphoma demonstrated an improved 2-year progression-free survival (PFS) over placebo. However, most patients a
Externí odkaz:
https://doaj.org/article/551d8a1644b244c18b60306f73172409
Publikováno v:
The Oncologist. 28:199-207
Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 24% of new cases of B-cell non-Hodgkin lymphoma in the US each year. Up to 50% of patients relapse or are refractory (R/R) to the standard first-line treatment option, R-CHOP. The anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74a5b809cec999fec4deace5f20b2c34
https://doi.org/10.1093/oncolo/oyac256
https://doi.org/10.1093/oncolo/oyac256
Autor:
Adrienne Nedved, N. Nora Bennani, Jade L. Kutzke, Heather P. May, Catherine E. DeFino, Jonathan G. Leung
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e194-e197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::172c4d9a32c9f7c1a115e7b1f3cd6985
https://doi.org/10.1016/j.clml.2020.10.010
https://doi.org/10.1016/j.clml.2020.10.010
Autor:
Jonas Paludo, Adrienne Nedved, Jason N. Barreto, Radhika Bansal, Jose C. Villasboas, Tuan A Truong, Patrick B. Johnston, N. Nora Bennani, Corina J Doleski, Stephen M. Ansell, Yi Lin, Matthew A. Hathcock, Justin R Hayne
Publikováno v:
American Journal of Hematology. 96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::416975e2c07fbcbeae7625c86bf8bfe1
https://doi.org/10.1002/ajh.26313
https://doi.org/10.1002/ajh.26313
Autor:
Arushi Khurana, Allison Rosenthal, Radhika Bansal, Matthew Hathcock, Adrienne Nedved, Yucai Wang, Jonas Paludo, Jose C Villasboas, Nora N Bennani, Patrick B Johnston, Stephen Ansell, Yi Lin
Publikováno v:
Transplantation and Cellular Therapy. 28:S197-S198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8acce9ca52c6090a07c8584d07deff8b
https://doi.org/10.1016/s2666-6367(22)00403-1
https://doi.org/10.1016/s2666-6367(22)00403-1
Autor:
Shaji Kumar, Gina Lange, Yi Lin, Rahma Warsame, Allison L McClanahan, Mustaqeem A. Siddiqui, Allison K.S. Matthews, Suzanne R. Hayman, N. Nora Bennani, Eva Brandes, Adrienne Nedved, Mithun Vinod Shah, Stephen M. Ansell, David Dingli, David P. Argue, Hassan B. Alkhateeb, Taxiarchis Kourelis, Prashant Kapoor, James Pringnitz, Saad S. Kenderian, Patrick B. Johnston, Nancy Pick, Lauren Seymour, Surbhi Sidana
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:QIM19-136
Background: The patient/caregiver experience during CAR-T therapy is stressful, overwhelming, terrifying, and often a patient’s last treatment option. The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery Inn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a6b9ded031f93e73e597531ed3e9748
https://doi.org/10.6004/jnccn.2018.7187
https://doi.org/10.6004/jnccn.2018.7187
Autor:
Jonas Paludo, Adrienne Nedved, Arushi Khurana, Radhika Bansal, Yucai Wang, Stephen M. Ansell, N. Nora Bennani, Patrick B. Johnston, Yi Lin, Jose C. Villasboas, Matthew A. Hathcock
Publikováno v:
Blood. 138:3842-3842
Background: Polatuzumab vedotin (Pola), an antibody drug conjugate targeting CD79b received FDA approval in combination with bendamustine and rituximab (Pola-BR) in June 2019. With CAR-T as destination therapy, the option of Pola-BR appears appealing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f9bd0ba5f1e66741dff5a0fface6f96
https://doi.org/10.1182/blood-2021-152313
https://doi.org/10.1182/blood-2021-152313
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36:1087-1094
Objective Assess the effects of linezolid on hematologic outcomes in newly diagnosed patients with acute myeloid leukemia (AML) following induction chemotherapy. Design Single-center, retrospective, observational, cohort study. Setting Large, tertiar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f25ffe83d1412b587f07430405d0f7dc
https://doi.org/10.1002/phar.1824
https://doi.org/10.1002/phar.1824
Autor:
Tuan Truong, Jilan Kubusek, Stephen M. Ansell, Jose Villasboas Bisneto, Nora N Bennani, Yi Lin, Justin Hayne, Jonas Paludo, Adrienne Nedved, Patrick B. Johnston
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S264
Chimeric Antigen Receptor T-Cell (CART) therapy remains a novel approach for the treatment of relapsed, refractory B-cell Lymphoma. Complications of CAR T-cell therapy including cytopenias, infections, cytokine release syndrome (CRS) and neurotoxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bac2fbea2b01c41df24cb776cafda448
https://doi.org/10.1016/j.bbmt.2019.12.429
https://doi.org/10.1016/j.bbmt.2019.12.429
Autor:
Stephen M. Ansell, Patrick B. Johnston, Jonas Paludo, Jilan Kubusek, Jose Villasboas Bisneto, Adrienne Nedved, Yi Lin, Nora N Bennani, Pritish K. Tosh, Justin Hayne
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S275
Chimeric Antigen Receptor T-Cell (CART) therapy is a promising therapeutic option for patients with relapsed, refractory lymphomas. Both immunosuppression and infections are complications reported in the post-CART setting. The objective of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd506687f0f737d146e0435b6d8fa32
https://doi.org/10.1016/j.bbmt.2019.12.446
https://doi.org/10.1016/j.bbmt.2019.12.446